醫療影像及報告實作指引
0.1.0 - DSTU0 ci-build

醫療影像及報告實作指引 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

ValueSet: ICD-O-3 Morphology

Official URL: https://hapi.fhir.tw/fhir/ValueSet/ICD-O-3-Morphology Version: 0.1.0
Draft as of 2024-07-29 Computable Name: Morphology

ICD-O-3 Morphology

References

Logical Definition (CLD)

Generated Narrative: ValueSet ICD-O-3-Morphology

 

Expansion

Generated Narrative: ValueSet

Expansion based on codesystem ICD-O-3 Morphology v0.1.0 (CodeSystem)

This value set contains 675 concepts

CodeSystemDisplay
  80003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNeoplasm, malignant / Blastoma, NOS / Tumor, malignant, NOS / Cancer / Malignancy / Unclassified tumor, malignant
  80013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTumor cells, malignant
  80023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant tumor, small cell type
  80033https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant tumor, giant cell type
  80043https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant tumor, spindle cell type / Malignant tumor, fusiform cell type
  80053https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant tumor, clear cell type
  80102https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma in situ, NOS / Intraepithelial carcinoma, NOS
  80103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma, NOS / Epithelial tumor, malignant / Heterotopia-associated carcinoma
  80113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelioma, malignant / Epithelioma, NOS
  80123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLarge cell carcinoma, NOS
  80133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLarge cell neuroendocrine carcinoma / Combined large cell neuroendocrine carcinoma
  80143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLarge cell carcinoma with rhabdoid phenotype
  80153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlassy cell carcinoma
  80203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma, undifferentiated, NOS / Carcinoma, poorly differentiated, NOS / Anaplastic undifferentiated carcinoma / Dedifferentiated carcinoma
  80213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma, anaplastic, NOS
  80223https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPleomorphic carcinoma
  80233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNuclear protein in testis (NUT) associated carcinoma / NUT carcinoma / NUT midline carcinoma
  80303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGiant cell and spindle cell carcinoma
  80313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGiant cell carcinoma
  80323https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle cell carcinoma, NOS
  80333https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPseudosarcomatous carcinoma / Sarcomatoid carcinoma
  80343https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPolygonal cell carcinoma
  80353https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma with osteoclast-like giant cells / Squamous carcinoma with osteoclast-like giant cells / Undifferentiated carcinoma with osteoclast-like giant cells
  80413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySmall cell carcinoma, NOS / Reserve cell carcinoma / Round cell carcinoma / Small cell neuroendocrine carcinoma / Small cell carcinoma, pulmonary type
  80423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOat cell carcinoma
  80433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySmall cell carcinoma, fusiform cell
  80443https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySmall cell carcinoma, intermediate cell / Small cell carcinoma, hypercalcaemic type
  80453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCombined small cell carcinoma / Mixed small cell carcinoma / Combined small cell-adenocarcinoma / Combined small cell-large cell carcinoma / Combined small cell-squamous cell carcinoma
  80463https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNon-small cell carcinoma
  80502https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary carcinoma in situ
  80503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary carcinoma, NOS
  80513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyVerrucous carcinoma, NOS / Verrucous epidermoid carcinoma / Verrucous squamous cell carcinoma
  80522https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary squamous cell carcinoma, non-invasive / Papillary squamous cell carcinoma in situ
  80523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary squamous cell carcinoma / Papillary epidermoid carcinoma
  80543https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyWarty carcinoma / Condylomatous carcinoma / Warty-basaloid carcinoma
  80702https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma in situ, NOS / Epidermoid carcinoma in situ, NOS / Intraepidermal carcinoma, NOS / Intraepithelial squamous cell carcinoma
  80703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, NOS / Squamous cell carcinoma, usual type / Epidermoid carcinoma, NOS / Squamous carcinoma / Squamous cell epithelioma
  80712https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDifferentiated intraepithelial neoplasia / Differentiated penile intraepithelial neoplasia (PeIN) / Differentiated vulva intraepithelial neoplasia (VIN)
  80713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, keratinizing, NOS / Epidermoid carcinoma, keratinizing / Squamous cell carcinoma, large cell, keratinizing / Keratoacanthoma
  80723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, large cell, nonkeratinizing, NOS / Epidermoid carcinoma, large cell, nonkeratinizing / Squamous cell carcinoma, nonkeratinizing, NOS
  80733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, small cell, nonkeratinizing / Epidermoid carcinoma, small cell, nonkeratinizing
  80743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, spindle cell / Epidermoid carcinoma, spindle cell / Squamous cell carcinoma, sarcomatoid / Pseudovascular squamous cell carcinoma
  80753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, adenoid / Squamous cell carcinoma, acantholytic / Squamous cell carcinoma, pseudoglandular
  80762https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma in situ with questionable stromal invasion / Epidermoid carcinoma in situ with questionable stromal invasion
  80763https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, microinvasive
  80772https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous intraepithelial neoplasia, high grade / Squamous intraepithelial neoplasia, grade III / Squamous dysplasia, high grade / High grade intra-epithelial lesion / Anal intraepithelial neoplasia, grade III / AIN III / Cervical intraepithelial neoplasia, grade III / CIN III, NOS / CIN III with severe dysplasia / Esophageal squamous intraepithelial neoplasia (dysplasia), high grade / Vaginal intraepithelial neoplasia, grade III / VAIN III / Vulvar intraepithelial neoplasia, grade III / VIN III
  80783https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma with horn formation
  80802https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyQueyrat erythroplasia
  80812https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBowen disease / Intraepidermal squamous cell carcinoma, Bowen type
  80823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLymphoepithelial carcinoma / Lymphoepithelioma / Lymphoepithelioma-like carcinoma / Schmincke tumor
  80833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasaloid squamous cell carcinoma / Papillary-basaloid carcinoma
  80843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, clear cell type
  80853https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, HPV-positive
  80863https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySquamous cell carcinoma, HPV-negative
  80903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasal cell carcinoma, NOS / Basal cell epithelioma / Rodent ulcer / Pigmented basal cell carcinoma / Basal cell carcinoma with adnexal differentiation
  80913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMultifocal superficial basal cell carcinoma / Multicentric basal cell carcinoma / Supeficial basal cell carcinoma
  80923https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfiltrating basal cell carcinoma, NOS / Infiltrating basal cell carcinoma, non-sclerosing / Infiltrating basal cell carcinoma, sclerosing / Basal cell carcinoma, desmoplastic type / Basal cell carcinoma, morpheic / Basal cell carcinoma, sarcomatoid
  80933https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasal cell carcinoma, fibroepithelial / Fibroepithelioma, NOS / Fibroepithelioma of Pinkus type / Fibroepithelial basal cell carcinoma, Pinkus type / Pinkus tumor
  80943https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasosquamous carcinoma / Mixed basal-squamous cell carcinoma
  80953https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMetatypical carcinoma
  80973https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasal cell carcinoma, nodular / Basal cell carcinoma, micronodular
  80983https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenoid basal carcinoma
  81003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTrichoblastic carcinoma / Trichoblastic carcinosarcoma
  81023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTrichilemmocarcinoma / Trichilemmal carcinoma
  81103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPilomatrix carcinoma / Matrical carcinoma / Pilomatricoma, malignant / Pilomatrixoma, malignant / Pilomatrical carcinoma
  81202https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTransitional cell carcinoma in situ / Urothelial carcinoma in situ
  81203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTransitional cell carcinoma, NOS / Urothelial carcinoma, NOS / Transitional carcinoma
  81213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySchneiderian carcinoma / Cylindrical cell carcinoma
  81223https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTransitional cell carcinoma, spindle cell / Transitional cell carcinoma, sarcomatoid / Urothelial carcinoma, spindle cell
  81233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasaloid carcinoma
  81243https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCloacogenic carcinoma
  81302https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary transitional cell carcinoma, non-invasive / Papillary urothelial carcinoma, non-invasive
  81303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary transitional cell carcinoma / Papillary urothelial carcinoma
  81313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTransitional cell carcinoma, micropapillary
  81402https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in situ, NOS
  81403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma, NOS / Adenocarcinoma, usual type / Carcinoma of Skene, Cowper and Littre Glands / Endolymphatic sac tumor / Parathyroid carcinoma / Acinar adenocarcinoma of prostate
  81413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyScirrhous adenocarcinoma / Carcinoma with productive fibrosis / Scirrhous carcinoma
  81423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLinitis plastica
  81433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySuperficial spreading adenocarcinoma
  81443https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma, intestinal type / Adenocarcinoma, enteric / Carcinoma, intestinal type
  81453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma, diffuse type / Adenocarcinoma, diffuse type
  81473https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasal cell adenocarcinoma / Basal cell carcinoma of the prostate
  81482https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlandular intraepithelial neoplasia, high grade / Glandular intraepithelial neoplasia, grade III / Flat intraepithelial neoplasia, high grade / Biliary intraepithelial neoplasia, high grade / Biliary intraepithelial neoplasia, grade 3 (BilIN-3) / Esophageal glandular dysplasia (intraepithelial neoplasia), high grade / Esophageal intraepithelial neoplasia, high grade / Flat intraepithelial glandular neoplasia, high grade / Flat intraepithelial neoplasia (dysplasia), high grade / Prostatic intraepithelial neoplasia, grade III / PIN III / Prostatic intraepithelial neoplasia, high grade
  81503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPancreatic endocrine tumor, NOS / Islet cell tumor, NOS / Islet cell adenocarcinoma / Islet cell carcinoma / Pancreatic endocrine tumor, nonfunctioning / Pancreatic neuroendocrine tumor, nonfunctioning
  81513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInsulinoma, NOS / Beta cell adenoma / Beta cell tumor, malignant
  81523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlucagonoma, NOS / Alpha cell tumor, NOS / Enteroglucagonoma, NOS / Glucagon-like peptide-producing tumor / L-cell tumor / Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor / PP/PYY producing tumor
  81533https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGastrinoma, NOS / G cell tumor, NOS / Gastrin cell tumor
  81543https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) / Mixed pancreatic endocrine and exocrine tumor, malignant / Mixed islet cell and exocrine adenocarcinoma / Mixed acinar-endocrine carcinoma / Mixed acinar-neuroendocrine carcinoma / Mixed acinar-endocrine-ductal carcinoma / Mixed ductal-endocrine carcinoma / Mixed ductal-neuroendocrine carcinoma / Mixed endocrine and exocrine adenocarcinoma
  81553https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyVipoma, NOS
  81563https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySomatostatinoma, NOS / Somatostatin cell tumor, NOS
  81583https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndocrine tumor, functioning, NOS / ACTH-producing tumor
  81603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCholangiocarcinoma / Bile duct adenocarcinoma / Bile duct carcinoma
  81613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBile duct cystadenocarcinoma
  81623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyKlatskin tumor
  81632https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia / Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia / Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia
  81633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPancreatobiliary-type carcinoma / Adenocarcinoma, pancreatobiliary type
  81703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatocellular carcinoma, NOS / Hepatoma, NOS / Hepatocarcinoma / Hepatoma, malignant / Liver cell carcinoma
  81713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatocellular carcinoma, fibrolamellar
  81723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatocellular carcinoma, scirrhous / Sclerosing hepatic carcinoma
  81733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatocellular carcinoma, spindle cell variant / Hepatocellular carcinoma, sarcomatoid
  81743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatocellular carcinoma, clear cell type
  81753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatocellular carcinoma, pleomorphic type
  81803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCombined hepatocellular carcinoma and cholangiocarcinoma / Hepatocholangiocarcinoma / Mixed hepatocellular and bile duct carcinoma
  81903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTrabecular adenocarcinoma / Trabecular carcinoma
  82003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenoid cystic carcinoma / Cylindroma, NOS / Adenocarcinoma, cylindroid / Adenocystic carcinoma / Bronchial adenoma, cylindroid / Thymic carcinoma with adenoid cystic carcinoma-like features
  82012https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCribriform carcinoma in situ / Ductal carcinoma in situ, cribriform type
  82013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCribriform carcinoma, NOS / Ductal carcinoma, cribriform type / Cribriform comedo-type carcinoma / Adenocarcinoma, cribriform comedo-type
  82102https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in situ in adenomatous polyp / Adenocarcinoma in situ in a polyp, NOS / Carcinoma in situ in a polyp, NOS / Adenocarcinoma in situ in polypoid adenoma / Adenocarcinoma in situ in tubular adenoma / Carcinoma in situ in adenomatous polyp
  82103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in adenomatous polyp / Adenocarcinoma in a polyp, NOS / Carcinoma in a polyp, NOS / Adenocarcinoma in polypoid adenoma / Adenocarcinoma in tubular adenoma / Carcinoma in adenomatous polyp
  82113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTubular adenocarcinoma / Tubular carcinoma
  82133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySerrated adenocarcinoma
  82143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyParietal cell carcinoma / Parietal cell adenocarcinoma
  82153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma of anal glands / Adenocarcinoma of anal ducts
  82203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in adenomatous polyposis coli
  82213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in multiple adenomatous polyps
  82302https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDuctal carcinoma in situ, solid type / Intraductal carcinoma, solid type
  82303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySolid carcinoma, NOS / Solid adenocarcinoma / Solid carcinoma with mucin formation / Solid adenocarcinoma with mucin formation
  82313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma simplex
  82403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoid tumor, NOS / Carcinoid, NOS / Bronchial adenoma, carcinoid / Neuroendocrine carcinoma, low grade / Neuroendocrine carcinoma, well-differentiated / Neuroendocrine tumor, grade I / Typical carcinoid
  82413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEnterochromaffin cell carcinoid / Argentaffinoma, malignant / Carcinoid tumor, argentaffin, malignant / EC cell carcinoid / Serotonin producing carcinoid / Serotonin producing tumor
  82423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEnterochromaffin-like cell tumor, malignant / ECL cell carcinoid, malignant
  82433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGoblet cell carcinoid / Mucinous carcinoid / Mucocarcinoid tumor
  82443https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed adenoneuroendocrine carcinoma / Combined carcinoid and adenocarcinoma / Combined/mixed carcinoid and adenocarcinoma / Composite carcinoid / MANEC / Mixed carcinoid-adenocarcinoma
  82453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoid tumor
  82463https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNeuroendocrine carcinoma, NOS / Poorly differentiated neuroendocrine neoplasm
  82473https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMerkel cell carcinoma / Merkel cell tumor / Primary cutaneous neuroendocrine carcinoma
  82493https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAtypical carcinoid tumor / Neuroendocrine carcinoma, moderately differentiated / Neuroendocrine tumor, grade 2
  82502https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in situ of the lung, non-mucinous
  82503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLepidic adenocarcinoma / Bronchiolo-alveolar adenocarcinoma, NOS / Bronchiolo-alveolar carcinoma, NOS / Alveolar cell carcinoma / Bronchiolar adenocarcinoma / Bronchiolar carcinoma
  82513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAlveolar adenocarcinoma / Alveolar carcinoma
  82523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBronchiolo-alveolar carcinoma, non- mucinous / Bronchiolo-alveolar carcinoma, Clara cell / Bronchiolo-alveolar carcinoma, type II pneumocyte
  82532https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in situ of the lung, mucinous
  82533https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBronchiolo-alveolar carcinoma, mucinous / Bronchiolo-alveolar carcinoma, goblet cell type / Adenocarcinoma of the lung, mucinous
  82543https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma of the lung, mixed mucinous and non-mucinous / Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous / Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type / Bronchiolo-alveolar carcinoma, indeterminate type / Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type
  82553https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma with mixed subtypes / Adenocarcinoma combined with other types of carcinoma
  82563https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMinimally invasive adenocarcinoma, non-mucinous
  82573https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMinimally invasive adenocarcinoma, mucinous
  82603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary adenocarcinoma, NOS / Papillary carcinoma of thyroid / Papillary renal cell carcinoma
  82612https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in situ in villous adenoma
  82613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in villous adenoma
  82623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyVillous adenocarcinoma
  82632https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in situ in tubulovillous adenoma
  82633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma in tubulovillous adenoma / Villoglandular carcinoma / Villoglandular variant of endometrioid adenocarcinoma / Papillotubular adenocarcinoma / Tubulopapillary adenocarcinoma
  82653https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMicropapillary carcinoma, NOS / Micropapillary adenocarcinoma
  82703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChromophobe carcinoma / Chromophobe adenocarcinoma
  82723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPituitary carcinoma, NOS
  82733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPituitary blastoma
  82803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcidophil carcinoma / Acidophil adenocarcinoma / Eosinophil adenocarcinoma / Eosinophil carcinoma
  82813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed acidophil-basophil carcinoma
  82903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOxyphilic adenocarcinoma / Oncocytic adenocarcinoma / Oncocytic carcinoma / Hurthle cell carcinoma / Hurthle cell adenocarcinoma / Follicular carcinoma, oxyphilic cell
  83003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBasophil carcinoma / Basophil adenocarcinoma / Mucoid cell adenocarcinoma
  83103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyClear cell adenocarcinoma, NOS / Clear cell carcinoma / Clear cell adenocarcinoma, mesonephroid / Clear cell renal cell carcinoma
  83113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHereditary leiomyomatosis and renal cell carcinoma (HRCC)-associated renal cell carcinoma / MiT Family translocation carcinoma
  83123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySuccinate dehydrogenase deficient renal cell carcinoma / Renal cell carcinoma, NOS / Renal cell adenocarcinoma / Renal cell carcinoma, unclassified / Grawitz tumor / Hypernephroma
  83133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyClear cell adenocarcinofibroma / Clear cell cystadenocarcinofibroma
  83143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLipid-rich carcinoma
  83153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlycogen-rich carcinoma / Glycogen-rich clear cell carcinoma
  83163https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCyst-associated renal cell carcinoma / Acquired cystic disease associated renal cell carcinoma / Tubulocystic renal cell carcinoma
  83173https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRenal cell carcinoma, chromophobe type / Chromophobe cell renal carcinoma / Hybrid oncocytic chromophobe tumor
  83183https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRenal cell carcinoma, sarcomatoid / Renal cell carcinoma, spindle cell
  83193https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCollecting duct carcinoma / Bellini duct carcinoma / Renal carcinoma, collecting duct type
  83203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGranular cell carcinoma / Granular cell adenocarcinoma
  83223https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyWater-clear cell adenocarcinoma / Water-clear cell carcinoma
  83233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed cell adenocarcinoma
  83303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular adenocarcinoma, NOS / Follicular carcinoma, NOS
  83313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular adenocarcinoma, well differentiated / Follicular carcinoma, well differentiated
  83323https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular adenocarcinoma, trabecular / Follicular carcinoma, trabecular / Follicular adenocarcinoma, moderately differentiated / Follicular carcinoma, moderately differentiated
  83333https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFetal adenocarcinoma
  83353https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular carcinoma, minimally invasive
  83373https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInsular carcinoma / Poorly differentiated thyroid carcinoma
  83393https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular carcinoma, encapsulated angioinvasive
  83403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary carcinoma, follicular variant / Papillary adenocarcinoma, follicular variant / Papillary and follicular adenocarcinoma / Papillary and follicular carcinoma
  83413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary microcarcinoma
  83423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary carcinoma, oxyphilic cell / Papillary carcinoma, oncocytic variant
  83433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary carcinoma, encapsulated
  83443https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary carcinoma, columnar cell / Papillary carcinoma, tall cell
  83453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedullary carcinoma with amyloid stroma / C cell carcinoma / Parafollicular cell carcinoma
  83463https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed medullary-follicular carcinoma
  83473https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed medullary-papillary carcinoma
  83503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNonencapsulated sclerosing carcinoma / Nonencapsulated sclerosing adenocarcinoma / Nonencapsulated sclerosing tumor / Papillary carcinoma, diffuse sclerosing
  83703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdrenal cortical carcinoma / Adrenal cortical adenocarcinoma / Adrenal cortical tumor, malignant
  83802https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrioid intraepithelial neoplasia / Atypical hyperplasia of the endometrium
  83803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrioid adenocarcinoma, NOS / Endometrioid carcinoma, NOS / Endometrioid cystadenocarcinoma
  83813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrioid adenofibroma, malignant / Endometrioid cystadenofibroma, malignant
  83823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrioid adenocarcinoma, secretory variant
  83833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrioid adenocarcinoma, ciliated cell variant
  83843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma, endocervical type
  83903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySkin appendage carcinoma / Adnexal carcinoma / Adnexal adenocarcinoma, NOS
  84003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySweat gland adenocarcinoma / Sweat gland carcinoma / Sweat gland tumor, malignant
  84013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyApocrine adenocarcinoma / Apocrine carcinoma
  84023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNodular hidradenoma, malignant / Hidradenocarcinoma
  84033https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant eccrine spiradenoma / Malignant neoplam arising from pre-existing spiradenoma / Malignant neoplam arising from pre-existing cylindroma / Malignant neoplam arising from pre-existing spiradenocylindroma
  84063https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySyringocystadenocarcinoma papilliferum
  84073https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySclerosing sweat duct carcinoma / Microcystic adnexal carcinoma / Syringomatous carcinoma
  84083https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEccrine papillary adenocarcinoma / Digital papillary adenocarcinoma
  84092https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPorocarcinoma in situ
  84093https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEccrine poroma, malignant / Porocarcinoma, NOS
  84103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySebaceous adenocarcinoma / Sebaceous carcinoma
  84133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEccrine adenocarcinoma
  84203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCeruminous adenocarcinoma / Ceruminous carcinoma
  84303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucoepidermoid carcinoma
  84403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCystadenocarcinoma, NOS
  84412https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySerous intraepithelial carcinoma / Serous tubal intraepithelial carcinoma (STIC) / Serous endometrial intraepithelial carcinoma
  84413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySerous cystadenocarcinoma, NOS / Serous adenocarcinoma, NOS / Serous carcinoma, NOS / Serous papillary adenocarcinoma, NOS
  84503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary cystadenocarcinoma, NOS / Papillocystic adenocarcinoma
  84523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySolid pseudopapillary carcinoma
  84532https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraductal papillary-mucinous carcinoma, non-invasive / Intraductal papillary mucinous neoplasm with high grade dysplasia
  84533https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraductal papillary-mucinous carcinoma, invasive / Intraductal papillary mucinous neoplasm with an associated invasive carcinoma
  84602https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySerous borderline tumor, micropapillary variant / Serous carcinoma, non invasive, low grade
  84603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLow grade serous carcinoma / Papillary serous cystadenocarcinoma / Papillary serous adenocarcinoma / Micropapillary serous carcinoma
  84613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHigh grade serous carcinoma / Serous surface papillary carcinoma / Primary serous papillary carcinoma of peritoneum
  84702https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucinous cystadenocarcinoma, non-invasive / Mucinous cystic tumor with high-grade dysplasia / Mucinous cystic neoplasm with high-grade dysplasia / Mucinous cystic neoplasm with high-grade intraepithelial neoplasia
  84703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucinous cystadenocarcinoma, NOS / Pseudomucinous cystadenocarcinoma, NOS / Pseudomucinous adenocarcinoma / Mucinous cystic tumor with an associated invasive carcinoma / Mucinous cystic neoplasm with an associated invasive carcinoma
  84713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary mucinous cystadenocarcinoma / Papillary pseudomucinous cystadenocarcinoma
  84743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySeromucinous carcinoma
  84803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucinous adenocarcinoma / Acinar adenocarcinoma, mucinous variant / Colloid adenocarcinoma / Colloid carcinoma / Gelatinous adenocarcinoma / Gelatinous carcinoma / Mucinous carcinoma / Mucoid adenocarcinoma / Mucoid carcinoma / Mucous adenocarcinoma / Mucous carcinoma / Pseudomyxoma peritonei with unknown primary site / Mucinous tubular and spindle cell carcinoma
  84813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucin-producing adenocarcinoma / Mucin-producing carcinoma / Mucin-secreting adenocarcinoma / Mucin-secreting carcinoma
  84823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucinous adenocarcinoma, endocervical type / Mucinous adenocarcinoma, endocervical, gastric type
  84903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySignet ring cell carcinoma / Signet ring cell adenocarcinoma / Acinar adenocarcinoma, signet ring-like variant / Mucinous carcinoma, signet ring cell type / Poorly cohesive carcinoma / Signet ring cell/histiocytoid carcinoma
  85002https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraductal carcinoma, noninfiltrating, NOS / Intraductal adenocarcinoma, noninfiltrating, NOS / Intraductal carcinoma, NOS / Ductal carcinoma in situ, NOS / DCIS, NOS / DIN 3 / Ductal intraepithelial neoplasia 3 / Cystic hypersecretory carcinoma / Cystic hypersecretory carcinoma, intraductal
  85003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfiltrating duct carcinoma, NOS / Invasive breast carcinoma of no special type / Duct adenocarcinoma, NOS / Duct carcinoma, NOS / Ductal carcinoma, NOS / Duct cell carcinoma / Infiltrating duct adenocarcinoma / Basal like carcinoma of breast / Adenocarcinoma of mammary gland type / Adenocarcinoma of anogenital mammary-like glands / Carcinoma of the male breast
  85012https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyComedocarcinoma, noninfiltrating / Ductal carcinoma in situ, comedo type / DCIS, comedo type
  85013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyComedocarcinoma, NOS
  85023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySecretory carcinoma / Juvenile carcinoma of breast
  85032https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNoninfiltrating intraductal papillary adenocarcinoma / Intraductal papillary adenocarcinoma, NOS / Intraductal papillary carcinoma, NOS / DCIS, papillary / Ductal carcinoma in situ, papillary / Noninfiltrating intraductal papillary carcinoma / Intraductal papilloma with DCIS / Intraductal papillary neoplasm with high grade intraepithelial neoplasia / Intracystic papillary neoplasm with high grade intraepithelial neoplasia / Intracystic papillary tumor with high grade dysplasia / Intracystic papillary tumor with high grade intraepithelial neoplasia / Intraductal papillary neoplasm with high grade dysplasia / Intraductal papillary tumor with high grade dysplasia / Intraductal papillary tumor with high grade intraepithelial neoplasia / Intraductal tubular-papillary neoplasm, high grade
  85033https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraductal papillary adenocarcinoma with invasion / Infiltrating papillary adenocarcinoma / Infiltrating and papillary adenocarcinoma / Papillary carcinoma of the breast / Intraductal papillary neoplasm with associated invasive carcinoma / Intracystic papillary neoplasm with associated invasive carcinoma
  85042https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEncapsulated papillary carcinoma / Noninfiltrating intracystic carcinoma / Encysted papillary carcinoma / Intracystic papillary carcinoma / Intracystic carcinoma, NOS / Intracystic papillary adenocarcinoma
  85043https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEncapsulated papillary carcinoma with invasion / Encysted papillary carcinoma with invasion / Intracystic papillary carcinoma with invasion
  85072https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraductal micropapillary carcinoma / Ductal carcinoma in situ, micropapillary / Intraductal carcinoma, clinging, high grade
  85073https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInvasive micropapillary carcinoma of breast / Micropapillary carcinoma of breast
  85092https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySolid papillary carcinoma in situ / Endocrine mucin-producing sweat gland carcinoma in situ
  85093https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySolid papillary carcinoma with invasion / Endocrine mucin-producing sweat gland carcinoma
  85103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedullary carcinoma, NOS / Medullary adenocarcinoma / Medullary-like carcinoma
  85123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedullary carcinoma with lymphoid stroma
  85133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAtypical medullary carcinoma
  85143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDuct carcinoma, desmoplastic type
  85192https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLobular carcinoma in situ, pleomorphic / LCIS, pleomorphic
  85202https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLobular carcinoma in situ, NOS / LCIS, NOS / Lobular carcinoma, noninfiltrating / Lobular carcinoma in situ, classic / Intraductal papilloma with lobular carcinoma in situ
  85203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLobular carcinoma, NOS / Infiltrating lobular carcinoma, NOS / Lobular adenocarcinoma / Tubulolobular carcinoma
  85213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfiltrating ductular carcinoma
  85222https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraductal carcinoma and lobular carcinoma in situ
  85223https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfiltrating duct and lobular carcinoma / Lobular and ductal carcinoma / Intraductal and lobular carcinoma / Infiltrating duct and lobular carcinoma in situ / Infiltrating lobular carcinoma and ductal carcinoma in situ
  85233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfiltrating duct mixed with other types of carcinoma / Infiltrating duct and colloid carcinoma / Infiltrating duct and cribriform carcinoma / Infiltrating duct and mucinous carcinoma / Infiltrating duct and tubular carcinoma
  85243https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfiltrating lobular mixed with other types of carcinoma
  85253https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPolymorphous adenocarcinoma / Polymorphous carcinoma / Terminal duct adenocarcinoma
  85303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInflammatory carcinoma / Inflammatory adenocarcinoma
  85403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPaget disease, mammary / Paget disease of breast
  85413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPaget disease and infiltrating duct carcinoma of breast
  85423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPaget disease, extramammary
  85433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPaget disease and intraductal carcinoma of breast
  85503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcinar cell carcinoma / Acinar adenocarcinoma / Acinar carcinoma / Acinic cell adenocarcinoma
  85513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcinar cell cystadenocarcinoma / Acinar adenocarcinoma of the lung
  85523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed acinar-ductal carcinoma
  85603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenosquamous carcinoma / Mixed adenocarcinoma and epidermoid carcinoma / Mixed adenocarcinoma and squamous cell carcinoma / Squamoid eccrine ductal carcinoma
  85623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelial-myoepithelial carcinoma
  85703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma with squamous metaplasia / Adenoacanthoma / Endometrioid carcinoma with squamous differentiation
  85713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma with cartilaginous and osseous metaplasia / Adenocarcinoma with cartilaginous metaplasia / Adenocarcinoma with osseous metaplasia
  85723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma with spindle cell metaplasia / Acinar adenocarcinoma, sarcomatoid variant / Fibromatosis-like metaplastic carcinoma
  85733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma with apocrine metaplasia / Carcinoma with apocrine metaplasia
  85743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenocarcinoma with neuroendocrine differentiation / Carcinoma with neuroendocrine differentiation / Adenocarcinoma admixed with neuroendocrine carcinoma
  85753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMetaplastic carcinoma, NOS
  85763https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatoid adenocarcinoma / Hepatoid carcinoma
  85803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymoma, NOS / Intrapulmonary thymoma / Sclerosing thymoma / Metaplastic thymoma
  85813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymoma, type A / Thymoma, medullary / Thymoma, spindle cell
  85823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymoma, type AB / Thymoma, mixed type
  85833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymoma, type B1 / Thymoma, lymphocyte-rich / Thymoma, lymphocytic / Thymoma, organoid / Thymoma, predominantly cortical
  85843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymoma, type B2 / Thymoma, cortical
  85853https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymoma, type B3 / Thymoma, atypical / Thymoma, epithelial / Well differentiated thymic carcinoma
  85863https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThymic carcinoma, NOS / Thymoma, type C
  85883https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle epithelial tumor with thymus-like element / SETTLE / Spindle epithelial tumor with thymus-like differentiation
  85893https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma showing thymus-like element / Carcinoma showing thymus-like differentiation / CASTLE / Intrathyroid thymic carcinoma
  86003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyThecoma, malignant
  86203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGranulosa cell tumor, NOS / Granulosa cell tumor, adult type / Granulosa cell carcinoma / Granulosa cell tumor, sarcomatoid
  86303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAndroblastoma, malignant / Arrhenoblastoma, malignant
  86313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySertoli-Leydig cell tumor, poorly differentiated / Sertoli-Leydig cell tumor, sarcomatoid
  86343https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySertoli-Leydig cell tumor, poorly differentiated, with heterologous elements
  86403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySertoli cell carcinoma
  86503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLeydig cell tumor, malignant / Interstitial cell tumor, malignant
  86703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySteroid cell tumor, malignant
  86803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyParaganglioma, NOS
  86813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySympathetic paraganglioma
  86823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyParasympathetic paraganglioma
  86903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlomus jugulare tumor, NOS / Jugular paraganglioma / Jugulotympanic paraganglioma
  86913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAortic body tumor / Aortic body paraganglioma / Aorticopulmonary paraganglioma
  86923https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarotid body tumor / Carotid body paraganglioma
  86933https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyExtra-adrenal paraganglioma, NOS / Nonchromaffin paraganglioma, NOS / Chemodectoma / Composite paraganglioma
  87003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPhaeochromocytoma, NOS / Adrenal medullary paraganglioma / Chromaffin paraganglioma / Chromaffin tumor / Chromaffinoma / Composite phaeochromocytoma / Phaeochromoblastoma
  87103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlomangiosarcoma / Glomoid sarcoma
  87113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlomus tumor, malignant
  87143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPerivascular epithelioid tumor, malignant / PEComa, malignant
  87202https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMelanoma in situ
  87203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant melanoma, NOS / Melanoma, NOS / Nevoid melanoma
  87213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNodular melanoma
  87223https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBalloon cell melanoma
  87233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant melanoma, regressing
  87283https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMeningeal melanomatosis
  87303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAmelanotic melanoma
  87403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant melanoma in junctional nevus
  87412https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecancerous melanosis, NOS
  87413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant melanoma in precancerous melanosis
  87422https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLentigo maligna / Hutchinson melanotic freckle, NOS
  87423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLentigo maligna melanoma / Malignant melanoma in Hutchinson melanotic freckle
  87433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySuperficial spreading melanoma / Low cumulative sun damage melanoma
  87443https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcral lentiginous melanoma, malignant / Acral melanoma
  87453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDesmoplastic melanoma, malignant / Desmoplastic melanoma, amelanotic / Neurotropic melanoma, malignant
  87463https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucosal lentiginous melanoma
  87613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant melanoma in giant pigmented nevus / Malignant melanoma in congenital melanocytic nevus
  87703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed epithelioid and spindle cell melanoma / Malignant Spitz tumor / Spitz melanoma / Spitzoid melanoma
  87713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelioid cell melanoma
  87723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle cell melanoma, NOS
  87733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle cell melanoma, type A
  87743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle cell melanoma, type B
  87803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBlue nevus, malignant / Melanoma arising in a blue nevus
  88003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySarcoma, NOS / Mesenchymal tumor, malignant / Soft tissue sarcoma / Soft tissue tumor, malignant
  88013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle cell sarcoma / Spindle cell sarcoma, undifferentiated
  88023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGiant cell sarcoma / Pleomorphic cell sarcoma / Pleomorphic cell sarcoma, undifferentiated / Pleomorphic sarcoma / Pleomorphic dermal sarcoma
  88033https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySmall cell sarcoma / Round cell sarcoma / Round cell sarcoma, undifferentiated
  88043https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelioid sarcoma / Epithelioid cell sarcoma / Epithelioid sarcoma, undifferentiated
  88053https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyUndifferentiated sarcoma
  88063https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDesmoplastic small round cell tumor
  88103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFibrosarcoma, NOS
  88113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyxofibrosarcoma / Fibromyxosarcoma
  88123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPeriosteal fibrosarcoma / Periosteal sarcoma, NOS
  88133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFascial fibrosarcoma
  88143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInfantile fibrosarcoma / Congenital fibrosarcoma
  88153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySolitary fibrous tumor, malignant / Solitary fibrous tumor/Hemangiopericytoma, grade 3
  88253https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyofibroblastic sarcoma
  88303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant fibrous histiocytoma / Undifferentiated high grade pleomorphic sarcoma of bone / Fibroxanthoma, malignant
  88323https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDermatofibrosarcoma, sarcomatous
  88403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyxosarcoma / Low grade fibromyxoid sarcoma / Sclerosing epithelioid fibrosarcoma
  88423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOssifying fibromyxoid tumor, malignant / Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
  88503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLiposarcoma, NOS / Fibroliposarcoma
  88513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLiposarcoma, well differentiated / Lipoma-like liposarcoma / Liposarcoma, differentiated / Inflammatory liposarcoma / Sclerosing liposarcoma
  88523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyxoid liposarcoma / Myxoliposarcoma
  88533https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRound cell liposarcoma
  88543https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPleomorphic liposarcoma
  88553https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed liposarcoma
  88573https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFibroblastic liposarcoma
  88583https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDedifferentiated liposarcoma
  88903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLeiomyosarcoma, NOS
  88913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelioid leiomyosarcoma
  88943https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAngiomyosarcoma
  88953https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyosarcoma
  88963https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyxoid leiomyosarcoma
  89003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRhabdomyosarcoma, NOS / Rhabdosarcoma
  89013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPleomorphic rhabdomyosarcoma, adult type / Pleomorphic rhabdomyosarcoma, NOS / Rhabdomyosarcoma, pleomorphic type
  89023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed type rhabdomyosarcoma / Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma
  89103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEmbryonal rhabdomyosarcoma, NOS / Rhabdomyosarcoma, embryonal type / Embryonal rhabdomyosarcoma, pleomorphic / Sarcoma botryoides / Botryoid sarcoma
  89123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpindle cell rhabdomyosarcoma / Sclerosing rhabdomyosarcoma / Rhabdomyosarcoma, spindle cell/sclerosing type
  89203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAlveolar rhabdomyosarcoma
  89213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRhabdomyosarcoma with ganglionic differentiation / Ectomesenchymoma
  89303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrial stromal sarcoma, NOS / Endometrial sarcoma, NOS / Endometrial stromal sarcoma, high grade / Endometrioid stromal sarcoma, high grade
  89313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEndometrial stromal sarcoma, low grade / Endolymphatic stromal myosis / Endometrioid stromal sarcoma, low grade / Endometrial stromatosis / Stromal endometriosis / Stromal myosis, NOS
  89333https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenosarcoma
  89343https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinofibroma
  89353https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyStromal sarcoma, NOS
  89363https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGastrointestinal stromal sarcoma / Gastrointestinal stromal tumor, malignant / GIST, malignant
  89403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed tumor, malignant, NOS / Mixed tumor, salivary gland type, malignant / Malignant chondroid syringoma
  89413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinoma in pleomorphic adenoma / Carcinoma ex pleomorphic adenoma
  89503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMullerian mixed tumor
  89513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMesodermal mixed tumor
  89593https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant cystic nephroma / Malignant multilocular cystic nephroma
  89603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNephroblastoma, NOS / Nephroma, NOS / Wilms tumor
  89633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant rhabdoid tumor / Rhabdoid sarcoma / Rhabdoid tumor, NOS
  89643https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyClear cell sarcoma of kidney
  89703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatoblastoma / Embryonal hepatoma / Hepatoblastoma, epithelioid / Hepatoblastoma, mixed epithelial-mesenchymal
  89713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPancreatoblastoma
  89723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPulmonary blastoma / Pneumoblastoma
  89733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPleuropulmonary blastoma
  89803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinosarcoma, NOS
  89813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCarcinosarcoma, embryonal
  89823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant myoepithelioma / Myoepithelial carcinoma / Myoepithelioma, infiltrating
  89833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdenomyoepithelioma with carcinoma / Malignant adenomyoepithelioma
  89903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMesenchymoma, malignant / Mixed mesenchymal sarcoma / Phosphaturic mesenchymal tumor, malignant
  89913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEmbryonal sarcoma
  90003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBrenner tumor, malignant
  90143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySerous adenocarcinofibroma / Malignant serous adenofibroma / Serous cystadenocarcinofibroma / Malignant serous cystadenofibroma
  90153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMucinous adenocarcinofibroma / Malignant mucinous adenofibroma / Mucinous cystadenocarcinofibroma / Malignant mucinous cystadenofibroma
  90203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPhyllodes tumor, malignant / Cystosarcoma phyllodes, malignant / Periductal stromal tumor, low grade
  90403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySynovial sarcoma, NOS / Synovioma, NOS / Synovioma, malignant
  90413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySynovial sarcoma, spindle cell / Synovial sarcoma, monophasic fibrous
  90423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySynovial sarcoma, epithelioid cell
  90433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySynovial sarcoma, biphasic
  90443https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyClear cell sarcoma, NOS / Clear cell sarcoma, of tendons and aponeuroses / Melanoma, malignant, of soft parts
  90453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBiphenotypic sinonasal sarcoma
  90503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMesothelioma, malignant / Mesothelioma, NOS
  90513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFibrous mesothelioma, malignant / Fibrous mesothelioma, NOS / Desmoplastic mesothelioma / Sarcomatoid mesothelioma / Spindled mesothelioma
  90523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelioid mesothelioma, malignant / Epithelioid mesothelioma, NOS
  90533https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMesothelioma, biphasic, malignant / Mesothelioma, biphasic, NOS
  90603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDysgerminoma
  90613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySeminoma, NOS
  90623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySeminoma, anaplastic / Seminoma with high mitotic index
  90633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpermatocytic seminoma / Spermatocytoma / Spermatocytic tumor
  90642https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntratubular malignant germ cells / Intratubular germ cell neoplasia / Germ cell neoplasia in situ
  90643https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGerminoma / Germ cell tumor, NOS
  90653https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGerm cell tumor, nonseminomatous
  90703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEmbryonal carcinoma, NOS / Embryonal adenocarcinoma
  90713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyYolk sac tumor / Embryonal carcinoma, infantile / Yolk sac tumor, pre-pubertal type / Endodermal sinus tumor / Orchioblastoma / Polyvesicular vitelline tumor / Hepatoid yolk sac tumor / Yolk sac tumor, post-pubertal type
  90723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPolyembryoma / Embryonal carcinoma, polyembryonal type
  90803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTeratoma, malignant, NOS / Embryonal teratoma / Teratoblastoma, malignant / Immature teratoma, malignant / Immature teratoma, NOS
  90813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTeratocarcinoma / Mixed embryonal carcinoma and teratoma / Teratocarcinosarcoma
  90823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant teratoma, undifferentiated / Malignant teratoma, anaplastic
  90833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant teratoma, intermediate
  90843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTeratoma with malignant transformation / Teratoma with somatic-type malignancies / Dermoid cyst with malignant transformation / Dermoid cyst with secondary tumor
  90853https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed germ cell tumor / Mixed teratoma and seminoma
  90863https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGerm cell tumor with associated hematological malignancy
  90903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyStruma ovarii, malignant
  91003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChoriocarcinoma, NOS / Chorioepithelioma / Chorionepithelioma
  91013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChoriocarcinoma combined with other germ cell elements / Choriocarcinoma combined with embryonal carcinoma / Choriocarcinoma combined with teratoma
  91023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant teratoma, trophoblastic
  91053https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTrophoblastic tumor, epithelioid
  91103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMesonephroma, malignant / Mesonephroma, NOS / Mesonephric adenocarcinoma / Wolffian duct carcinoma / Adenocarcinoma of rete ovarii
  91203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHemangiosarcoma / Angiosarcoma
  91243https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyKupffer cell sarcoma
  91303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHemangioendothelioma, malignant / Hemangioendothelial sarcoma
  91333https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpithelioid hemangioendothelioma, NOS / Epithelioid hemangioendothelioma, malignant / Intravascular bronchial alveolar tumor
  91373https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntimal sarcoma
  91403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyKaposi sarcoma / Multiple hemorrhagic sarcoma
  91503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHemangiopericytoma, malignant
  91703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLymphangiosarcoma / Lymphangioendothelial sarcoma / Lymphangioendothelioma, malignant
  91803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOsteosarcoma, NOS / Osteogenic sarcoma, NOS / Osteoblastic sarcoma / Osteochondrosarcoma / Osteosarcoma, extraskeletal
  91813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChondroblastic osteosarcoma
  91823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFibroblastic osteosarcoma / Osteofibrosarcoma
  91833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTelangiectatic osteosarcoma
  91843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOsteosarcoma in Paget disease of bone / Secondary osteosarcoma
  91853https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySmall cell osteosarcoma / Round cell osteosarcoma
  91863https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCentral osteosarcoma / Conventional central osteosarcoma / Medullary osteosarcoma
  91873https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntraosseous well differentiated osteosarcoma / Intraosseous low grade osteosarcoma / Low grade central osteosarcoma
  91923https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyParosteal osteosarcoma / Juxtacortical osteosarcoma
  91933https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPeriosteal osteosarcoma
  91943https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHigh grade surface osteosarcoma
  91953https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntracortical osteosarcoma
  92203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChondrosarcoma, NOS / Fibrochondrosarcoma / Chondrosarcoma, grade 2 / Chondrosarcoma, grade 3
  92213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyJuxtacortical chondrosarcoma / Periosteal chondrosarcoma
  92303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChondroblastoma, malignant
  92313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyxoid chondrosarcoma
  92403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMesenchymal chondrosarcoma
  92423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyClear cell chondrosarcoma
  92433https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDedifferentiated chondrosarcoma
  92503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGiant cell tumor of bone, malignant / Giant cell sarcoma of bone / Osteoclastoma, malignant
  92513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant giant cell tumor of soft parts
  92523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant tenosynovial giant cell tumor / Giant cell tumor of tendon sheath, malignant
  92603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEwing sarcoma / Ewing tumor
  92613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdamantinoma of long bones / Tibial adamantinoma
  92703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOdontogenic tumor, malignant / Ameloblastic carcinoma / Odontogenic carcinoma / Odontogenic sarcoma / Primary intraosseous carcinoma
  92903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAmeloblastic odontosarcoma / Ameloblastic fibro-odontosarcoma / Ameloblastic fibrodentinosarcoma
  93023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGhost cell odontogenic carcinoma
  93103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAmeloblastoma, malignant / Adamantinoma, malignant
  93303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAmeloblastic fibrosarcoma / Ameloblastic sarcoma / Odontogenic fibrosarcoma
  93413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyClear cell odontogenic carcinoma / Clear cell odontogenic tumor
  93423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOdontogenic carcinosarcoma
  93623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPineoblastoma / Mixed pineal tumor / Mixed pineocytoma-pineoblastoma / Pineal parenchymal tumor of intermediate differentiation / Transitional pineal tumor
  93643https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPeripheral neuroectodermal tumor / Ewing sarcoma / Neuroectodermal tumor, NOS / Peripheral primitive neuroectodermal tumor, NOS / PPNET
  93653https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAskin tumor
  93703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChordoma, NOS
  93713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChondroid chordoma
  93723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDedifferentiated chordoma
  93803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlioma, malignant / Glioma, NOS
  93813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGliomatosis cerebri
  93823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed glioma / Anaplastic oligoastrocytoma / Oligoastrocytoma
  93853https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDiffuse midline glioma, H3 K27M-mutant / Diffuse intrinsic pontine glioma, H3 K27M-mutation
  93903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChoroid plexus carcinoma / Choroid plexus papilloma, anaplastic / Choroid plexus papilloma, malignant
  93913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpendymoma, NOS / Epithelial ependymoma / Cellular ependymoma / Clear cell ependymoma / Tanycytic ependymoma
  93923https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpendymoma, anaplastic / Ependymoblastoma
  93933https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary ependymoma
  93953https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary tumor of the pineal region
  93963https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEpendymoma, RELA fusion-positive
  94003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAstrocytoma, NOS / Astrocytic glioma / Astroglioma / Astrocytoma, low grade / Cystic astrocytoma / Diffuse astrocytoma / Diffuse astrocytoma, low grade / Diffuse astrocytoma, IDH-mutant
  94013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAstrocytoma, anaplastic / Astrocytoma, anaplastic, IDH-mutant
  94103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyProtoplasmic astrocytoma
  94113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGemistocytic astrocytoma / Gemistrocytc astrocytoma, IDH-mutant / Gemistocytoma
  94203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFibrillary astrocytoma / Fibrous astrocytoma
  94233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPolar spongioblastoma / Primitive polar spongioblastoma / Spongioblastoma polare
  94243https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPleomorphic xanthoastrocytoma / Anaplastic pleomorphic xanthoastrocytoma
  94253https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPilomyxoid astrocytoma
  94303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAstroblastoma
  94403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlioblastoma, NOS / Epithelioid glioblastoma / Glioblastoma, IDH-wildtype / Glioblastoma, primary, NOS / Glioblastoma multiforme / Spongioblastoma multiforme / Diffuse midline glioma, NOS / Diffuse intrinsic pontine glioma
  94413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGiant cell glioblastoma / Monstrocellular sarcoma
  94423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGliosarcoma / Glioblastoma with sarcomatous component
  94453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGlioblastoma, IDH-mutant / Glioblastoma, secondary, IDH-mutant / Glioblastoma, secondary, NOS
  94503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOligodendroglioma, NOS / Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
  94513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOligodendroglioma, anaplastic / Oligodendroglioma, anaplastic, IDH-mutant and 1p/19q codeleted
  94603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOligodendroblastoma
  94703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedulloblastoma, NOS / Classic medulloblastoma / Melanotic medulloblastoma
  94713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyDesmoplastic nodular medulloblastoma / Circumscribed arachnoidal cerebellar sarcoma / Desmoplastic medulloblastoma / Medulloblastoma with extensive nodularity / Medulloblastoma, SHH-activated and TP53-wildtype / Medulloblastoma, SHH activated, NOS
  94723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedullomyoblastoma
  94733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrimitive neuroectodermal tumor, NOS / PNET, NOS / Central primitive neuroectodermal tumor, NOS / CPNET / Supratentorial PNET / CNS Embryonal tumor, NOS / Embryonal CNS tumor with rhabdoid features
  94743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLarge cell medulloblastoma / Anaplastic medulloblastoma
  94753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedulloblastoma, WNT-activated, classic / Medulloblastoma, WNT-activated, large cell type / Medulloblastoma, WNT-activated, anaplastic type
  94763https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedulloblastoma, SHH-activated and TP53-mutant
  94773https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMeduloblastoma, non-WNT/non-SHH
  94783https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEmbryonal tumor with multilayered rosettes with C19MC alteration / Embryonal tumor with abundant neuropil and true rosettes / Embryonal tumor with multilayered rosettes, NOS
  94803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCerebellar sarcoma, NOS
  94903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGanglioneuroblastoma / CNS ganglioneuroblastoma
  95003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNeuroblastoma, NOS / Central neuroblastoma / CNS neuroblastoma / Sympathicoblastoma
  95013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMedulloepithelioma, NOS / Diktyoma, malignant
  95023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTeratoid medulloepithelioma
  95033https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNeuroepithelioma, NOS
  95043https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySpongioneuroblastoma
  95053https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGanglioglioma, anaplastic
  95083https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAtypical teratoid/rhabdoid tumor / CNS embryonal tumor with rhabdoid features
  95103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRetinoblastoma, NOS
  95113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRetinoblastoma, differentiated
  95123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRetinoblastoma, undifferentiated
  95133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRetinoblastoma, diffuse
  95203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOlfactory neurogenic tumor
  95213https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOlfactory neurocytoma / Esthesioneurocytoma
  95223https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOlfactory neuroblastoma / Esthesioneuroblastoma
  95233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyOlfactory neuroepithelioma / Esthesioneuroepithelioma
  95303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMeningioma, malignant / Leptomeningeal sarcoma / Meningeal sarcoma / Meningioma, anaplastic / Meningothelial sarcoma
  95383https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPapillary meningioma / Rhabdoid meningioma
  95393https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMeningeal sarcomatosis
  95403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant peripheral nerve sheath tumor / MPNST, NOS / Neurofibrosarcoma / Neurogenic sarcoma / Neurosarcoma / Melanotic MPNST / Melanotic psammomatous MPNST / MPNST with glandular differentiation / MPNST with mesenchymal differentiation / MPNST with perineurial differentiation
  95423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant peripheral nerve sheath tumor, epithelioid / Epithelioid MPNST
  95603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNeurilemoma, malignant / Malignant schwannoma, NOS / Neurilemosarcoma
  95613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation / Malignant schwannoma with rhabdomyoblastic differentiation / MPNST with rhabdomyoblastic differentiation / Triton tumor, malignant
  95713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPerineurioma, malignant / Perineural MPNST
  95803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyGranular cell tumor, malignant / Granular cell myoblastoma, malignant
  95813https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAlveolar soft part sarcoma
  95903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, NOS / Lymphoma, NOS / Microglioma
  95913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, non-Hodgkin, NOS / Non-Hodgkin lymphoma, NOS / B cell lymphoma, NOS / Lymphosarcoma, NOS / Lymphosarcoma, diffuse / Malignant lymphoma, diffuse, NOS / Malignant lymphoma, non-cleaved cell, NOS / Reticulum cell sarcoma, NOS / Reticulosarcoma, NOS / Reticulum cell sarcoma, diffuse / Reticulosarcoma, diffuse / Hairy cell leukemia variant / Malignant lymphoma, lymphocytic, intermediate differentiation, nodular / Malignant lymphoma, lymphocytic, poorly differentiated, diffuse / Malignant lymphoma, cleaved cell, NOS / Malignant lymphoma, small cleaved cell, NOS / Malignant lymphoma, small cell, noncleaved, diffuse / Malignant lymphoma, undifferentiated cell type, NOS / Malignant lymphoma, undifferentiated cell, non-Burkitt / Malignant lymphoma, small cleaved cell, diffuse / Splenic B-cell lymphoma/leukemia, unclassifiable / Splenic diffuse red pulp small B-cell lymphoma
  95963https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyComposite Hodgkin and non-Hodgkin lymphoma / B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma
  95973https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrimary cutaneous follicle centre lymphoma
  96503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, NOS / Hodgkin disease, NOS / Malignant lymphoma, Hodgkin / Classical Hodgkin lymphoma post-transplant lymphoproliferative disease
  96513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, lymphocyte-rich / Classical Hodgkin lymphoma, lymphocyte- rich / Hodgkin disease, lymphocyte predominance, NOS / Hodgkin disease, lymphocyte predominance, diffuse / Hodgkin disease, lymphocytic-histiocytic predominance
  96523https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, mixed cellularity, NOS / Classical Hodgkin lymphoma, mixed cellularity, NOS
  96533https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, lymphocyte depletion, NOS / Classical Hodgkin lymphoma, lymphocyte depletion, NOS
  96543https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, lymphocyte depletion, diffuse fibrosis / Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
  96553https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, lymphocyte depletion, reticular / Classical Hodgkin lymphoma, lymphocyte depletion, reticular
  96593https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, nodular lymphocyte predominance / Hodgkin paragranuloma, NOS / Hodgkin lymphoma, lymphocyte predominance, nodular / Hodgkin paragranuloma, nodular
  96613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin granuloma
  96623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin sarcoma
  96633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, nodular sclerosis, NOS / Classical Hodgkin lymphoma, nodular sclerosis, NOS / Hodgkin disease, nodular sclerosis, NOS
  96643https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, nodular sclerosis, cellular phase / Classical Hodgkin lymphoma, nodular sclerosis, cellular phase
  96653https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, nodular sclerosis, grade 1 / Classical Hodgkin lymphoma, nodular sclerosis, grade 1 / Hodgkin disease, nodular sclerosis, lymphocyte predominance / Hodgkin disease, nodular sclerosis, mixed cellularity
  96673https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHodgkin lymphoma, nodular sclerosis, grade 2 / Classical Hodgkin lymphoma, nodular sclerosis, grade 2 / Hodgkin disease, nodular sclerosis, lymphocyte depletion / Hodgkin disease, nodular sclerosis, syncytial variant
  96703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, small B lymphocytic, NOS / Malignant lymphoma, lymphocytic, NOS / Malignant lymphoma, lymphocytic, diffuse, NOS / Malignant lymphoma, small cell, NOS / Malignant lymphoma, small lymphocytic, NOS / Malignant lymphoma, lymphocytic, well differentiated, diffuse / Malignant lymphoma, small cell diffuse / Malignant lymphoma, small lymphocytic, diffuse
  96713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, lymphoplasmacytic / Malignant lymphoma, lymphoplasmacytoid / Immunocytoma / Malignant lymphoma, plasmacytoid / Plasmacytic lymphoma
  96733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMantle cell lymphoma / Malignant lymphoma, centrocytic / Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse / Malignant lymphomatous polyposis / Mantle zone lymphoma
  96753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, mixed small and large cell, diffuse / Malignant lymphoma, centroblastic- centrocytic, NOS / Malignant lymphoma, centroblastic- centrocytic, diffuse / Malignant lymphoma, mixed cell type, diffuse / Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse
  96783https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrimary effusion lymphoma
  96793https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMediastinal large B-cell lymphoma / Thymic large B-cell lymphoma
  96803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, large B-cell, diffuse, NOS / Diffuse large B-cell lymphoma, NOS / Malignant lymphoma, histiocytic, NOS / Malignant lymphoma, large B-cell, NOS / Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS / Malignant lymphoma, large cell, NOS / Malignant lymphoma, large cell, cleaved, NOS / Malignant lymphoma, large cell, diffuse, NOS / Malignant lymphoma, large cell, noncleaved, NOS / Malignant lymphoma, large cleaved cell, NOS / Malignant lymphoma, noncleaved, NOS / Malignant lymphoma, noncleaved, diffuse, NOS / Malignant lymphoma, histiocytic, diffuse / Malignant lymphoma, large cell, cleaved and noncleaved / Malignant lymphoma, large cell, cleaved, diffuse / Malignant lymphoma, large cell, noncleaved, diffuse / Malignant lymphoma, centroblastic, NOS / Malignant lymphoma, centroblastic, diffuse / Anaplastic large B-cell lymphoma / B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma / Diffuse large B-cell lymphoma associated with chronic inflammation / EBV positive diffuse large B-cell lymphoma / Intravascular large B-cell lymphoma / Intravascular B-cell lymphoma / Angioendotheliomatosis / Angiotropic lymphoma / Primary cutaneous DLBCL, leg type / Primary diffuse large B-cell lymphoma of the CNS / Histiocyte-rich large B-cell lymphoma / High-grade B-cell lymphoma, NOS / High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements / Vitreoretinal lymphoma
  96843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant lymphoma, large B-cell, diffuse, immunoblastic, NOS / Malignant lymphoma, immunoblastic, NOS / Immunoblastic sarcoma / Malignant lymphoma, large cell, immunoblastic
  96873https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBurkitt lymphoma, NOS / Burkitt tumor / Malignant lymphoma, small noncleaved, Burkitt type / Malignant lymphoma, undifferentiated, Burkitt type / Burkitt-like lymphoma, NOS / Burkitt-like lymphoma with 11q aberration
  96883https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyT-cell/histiocyte rich large B-cell lymphoma / T-cell rich large B-cell lymphoma
  96893https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySplenic marginal zone B-cell lymphoma / Splenic marginal zone lymphoma, NOS / Splenic lymphoma with villous lymphocytes
  96903https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular lymphoma, NOS / Malignant lymphoma, follicle center, NOS / Malignant lymphoma, follicular, NOS / Malignant lymphoma, lymphocytic, nodular, NOS / Malignant lymphoma, nodular, NOS / Malignant lymphoma, centroblastic- centrocytic, follicular / Malignant lymphoma, follicle center, follicular
  96913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular lymphoma, grade 2 / Malignant lymphoma, mixed cell type, follicular / Malignant lymphoma, mixed cell type, nodular / Malignant lymphoma, mixed lymphocytic-histiocytic, nodular / Malignant lymphoma, mixed small cleaved and large cell, follicular
  96953https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular lymphoma, grade 1 / Follicular lymphoma, small cleaved cell / Malignant lymphoma, lymphocytic, poorly differentiated, nodular / Malignant lymphoma, small cleaved cell, follicular / Duodenal-type follicular lymphoma
  96983https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular lymphoma, grade 3 / Malignant lymphoma, large cell, follicular, NOS / Malignant lymphoma, noncleaved cell, follicular, NOS / Follicular lymphoma, grade 3A / Follicular lymphoma, grade 3B / Malignant lymphoma, centroblastic, follicular / Malignant lymphoma, histiocytic, nodular / Malignant lymphoma, large cell, noncleaved, follicular / Malignant lymphoma, large cleaved cell, follicular / Malignant lymphoma, lymphocytic, well differentiated, nodular / Large B-cell lymphoma with IRF4 rearrangement
  96993https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMarginal zone B-cell lymphoma, NOS / Marginal zone lymphoma, NOS / BALT lymphoma / Bronchial-associated lymphoid tissue lymphoma / MALT lymphoma / Monocytoid B-cell lymphoma / Mucosal-associated lymphoid tissue lymphoma / Nodal marginal zone lymphoma / SALT lymphoma / Skin-associated lymphoid tissue lymphoma / Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue / Primary choroidal lymphoma
  97003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMycosis fungoides / Pagetoid reticulosis / Granulomatous slack skin
  97013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySezary syndrome / Sezary disease
  97023https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMature T-cell lymphoma, NOS / Peripheral T-cell lymphoma, NOS / T-cell lymphoma, NOS / Peripheral T-cell lymphoma, large cell / Peripheral T-cell lymphoma, pleomorphic medium and large cell / Peripheral T-cell lymphoma, pleomorphic small cell / T-zone lymphoma / Lymphoepithelioid lymphoma / Lennert lymphoma / Follicular T-cell lymphoma / Nodal peripheral T-cell lymphoma with T follicular helper phenotype
  97053https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAngioimmunoblastic T-cell lymphoma / Angioimmunoblastic lymphoma / Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia)
  97083https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySubcutaneous panniculitis-like T-cell lymphoma
  97093https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyCutaneous T-cell lymphoma, NOS / Cutaneous lymphoma, NOS / Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma / Primary cutaneous acral CD8-positive T-cell lymphoma
  97123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntravascular large B-cell lymphoma
  97143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAnaplastic large cell lymphoma, T cell and Null cell type / Large cell (Ki-1+) lymphoma / Anaplastic large cell lymphoma, NOS / Anaplastic large cell lymphoma, CD30+ / Anaplastic large cell lymphoma, ALK positive
  97153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAnaplastic large cell lymphoma, ALK negative / Breast implant-associated anaplastic large cell lymphoma
  97163https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHepatosplenic T-cell lymphoma / Hepatosplenic gamma-delta cell lymphoma
  97173https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyIntestinal T-cell lymphoma / Enteropathy associated T-cell lymphoma / Enteropathy type intestinal T-cell lymphoma / Monomorphic epitheliotropic intestinal T-cell lymphoma
  97183https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrimary cutaneous anaplastic large cell lymphoma / Primary cutaneous CD30+ large T-cell lymphoma
  97193https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyNK/T-cell lymphoma, nasal and nasal-type / Malignant reticulosis, NOS / Angiocentric T-cell lymphoma / Extranodal NK/T-cell lymphoma, nasal type / Malignant midline reticulosis / Polymorphic reticulosis / T/NK-cell lymphoma
  97243https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologySystemic EBV positive T-cell lymphoproliferative disease of childhood
  97263https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrimary cutaneous gamma-delta T-cell lymphoma
  97273https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecursor cell lymphoblastic lymphoma, NOS / Malignant lymphoma, lymphoblastic, NOS / Lymphoblastoma / Malignant lymphoma, convoluted cell / Blastic NK cell lymphoma / Blastic plasmacytoid dendritic cell neoplasm
  97283https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecursor B-cell lymphoblastic lymphoma
  97293https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecursor T-cell lymphoblastic lymphoma
  97313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPlasmacytoma, NOS / Plasma cell tumor / Plasmacytoma of bone / Solitary myeloma / Solitary plasmacytoma
  97323https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMultiple myeloma / Myeloma, NOS / Myelomatosis / Plasma cell myeloma
  97333https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPlasma cell leukemia / Plasmacytic leukemia
  97343https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPlasmacytoma, extramedullary / Extraosseous plasmacytoma
  97353https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPlasmablastic lymphoma
  97373https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyALK positive large B-cell lymphoma
  97383https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLarge B-cell lymphoma arising in HHV8-associated multicentric Castleman disease / HHV8-positive diffuse large B-cell lymphoma
  97403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMast cell sarcoma / Malignant mast cell tumor / Malignant mastocytoma
  97413https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant mastocytosis / Systemic tissue mast cell disease / Aggressive systemic mastocytosis / Systemic mastocytosis with AHNMD / Systemic mastocytosis with associated hematological clonal non-mast cell disorder
  97423https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMast cell leukemia
  97493https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyErdheim-Chester disease
  97503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMalignant histiocytosis / Histiocytic medullary reticulosis
  97513https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLangerhans cell histiocytosis, disseminated / Langerhans cell granulomatosis / Eosinophilic granuloma / Acute progressive histiocytosis X / Histiocytosis X, NOS / Hand-Schuller-Christian disease / Letterer-Siwe disease / Nonlipid reticuloendotheliosis
  97553https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHistiocytic sarcoma / True histiocytic lymphoma
  97563https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLangerhans cell sarcoma
  97573https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyInterdigitating dendritic cell sarcoma / Interdigitating cell sarcoma / Dendritic cell sarcoma, NOS / Indeterminate dendritic cell tumor
  97583https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFollicular dendritic cell sarcoma / Follicular dendritic cell tumor
  97593https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyFibroblastic reticular cell tumor
  97603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyImmunoproliferative disease, NOS
  97613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyWaldenstrom macroglobulinemia
  97623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHeavy chain disease, NOS / Alpha heavy chain disease / Gamma heavy chain disease / Franklin disease / Mu heavy chain disease
  97643https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyImmunoproliferative small intestinal disease / Mediterranean lymphoma
  97663https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLymphomatoid granulomatosis, grade 3
  98003https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLeukemia, NOS / Aleukemic leukemia, NOS / Chronic leukemia, NOS / Subacute leukemia, NOS
  98013https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute leukemia, NOS / Blast cell leukemia / Stem cell leukemia / Undifferentiated leukemia
  98053https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute biphenotypic leukemia / Acute bilineal leukemia / Acute mixed lineage leukemia
  98063https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
  98073https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed phenotype acute leukemia with t(v;11q23); MLL rearranged
  98083https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed phenotype acute leukemia, B/myeloid, NOS
  98093https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMixed phenotype acute leukemia, T/myeloid, NOS
  98113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma, NOS / B lymphoblastic leukemia/lymphoma with iAMP21
  98123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
  98133https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged
  98143https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
  98153https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with hyperdiploidy
  98163https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL)
  98173https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
  98183https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
  98193https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB lymphoblastic leukemia/lymphoma, BCR-ABL1–like
  98203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyLymphoid leukemia, NOS / Lymphatic leukemia, NOS / Lymphocytic leukemia, NOS / Aleukemic lymphoid leukemia / Aleukemic lymphatic leukemia / Aleukemic lymphocytic leukemia / Lymphosarcoma cell leukemia / Subacute lymphoid leukemia / Subacute lymphatic leukemia / Subacute lymphocytic leukemia
  98233https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyB-cell chronic lymphocytic leukemia/small lymphocytic lymphoma / Chronic lymphatic leukemia / Chronic lymphocytic leukemia / Chronic lymphocytic leukemia, B-cell type / Chronic lymphoid leukemia
  98263https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyBurkitt cell leukemia / Acute leukemia, Burkitt type / Acute lymphoblastic leukemia, mature B-cell type / B-ALL / FAB L3
  98273https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAdult T-cell leukemia/lymphoma (HTLV-1 positive) / Adult T-cell leukemia / Adult T-cell lymphoma / Adult T-cell lymphoma/leukemia
  98313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyT-cell large granular lymphocytic leukemia / Large granular lymphocytosis, NOS / NK-cell large granular lymphocytic leukemia / T-cell large granular lymphocytosis / Chronic lymphoproliferative disorder of NK cells
  98323https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyProlymphocytic leukemia, NOS
  98333https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyProlymphocytic leukemia, B-cell type
  98343https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyProlymphocytic leukemia, T-cell type
  98353https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecursor cell lymphoblastic leukemia, NOS / Acute lymphoblastic leukemia, NOS / Acute lymphoblastic leukemia, L2 type, NOS / Acute lymphoblastic leukemia-lymphoma, NOS / Lymphoblastic leukemia, NOS / Acute lymphatic leukemia / Acute lymphocytic leukemia / Acute lymphoid leukemia / FAB L1 / FAB L2 / Precursor cell lymphoblastic leukemia, not phenotyped / Acute lymphoblastic leukemia, precursor-cell type
  98363https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecursor B-cell lymphoblastic leukemia / c-ALL / Common ALL / Common precursor B ALL / Pre-B ALL / Pre-pre-B ALL / Pro-B ALL
  98373https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrecursor T-cell lymphoblastic leukemia / Cortical T ALL / Mature T ALL / Pre-T ALL / Pro-T ALL / T lymphoblastic leukemia/lymphoma / Early T-cell precursor acute lymphoblastic leukemia
  98403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia, M6 type / Acute erythremia / Acute erythremic myelosis / Acute erythroid leukemia / AML M6 / Di Guglielmo disease / Erythremic myelosis, NOS / Erythroleukemia / FAB M6 / M6A / M6B
  98603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid leukemia, NOS / Granulocytic leukemia, NOS / Myelocytic leukemia, NOS / Myelogenous leukemia, NOS / Myelomonocytic leukemia, NOS / Non-lymphocytic leukemia, NOS / Aleukemic myeloid leukemia / Aleukemic granulocytic leukemia / Aleukemic myelogenous leukemia / Aleukemic monocytic leukemia / Chronic monocytic leukemia / Eosinophilic leukemia / Monocytic leukemia, NOS / Subacute monocytic leukemia / Subacute myeloid leukemia / Subacute granulocytic leukemia / Subacute myelogenous leukemia
  98613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia, NOS / Acute granulocytic leukemia / Acute myelocytic leukemia / Acute myelogenous leukemia / Acute non-lymphocytic leukemia
  98633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChronic myeloid leukemia, NOS / Chronic granulocytic leukemia, NOS / Chronic myelocytic leukemia, NOS / Chronic myelogenous leukemia, NOS
  98653https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214
  98663https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute promyelocytic leukemia, t(15;17)(q22;q11-12) / Acute promyelocytic leukemia, NOS / Acute myeloid leukemia, PML/RAR-alpha / Acute myeloid leukemia, t(15;17)(q22;q11-12) / Acute promyelocytic leukemia, PML/RAR-alpha / FAB M3
  98673https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myelomonocytic leukemia / FAB M4
  98693https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with inv(3)(q21;q26.2) or t(13.3)(q21;q26.2); RPN1-EVI1
  98703https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute basophilic leukemia
  98713https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with abnormal marrow eosinophils / Acute myeloid leukemia, CBF-beta/MYH11 / Acute myeloid leukemia, inv(16)(p13;q22) / Acute myeloid leukemia, t(16;16)(p13;q11) / Acute myelomonocytic leukemia with abnormal eosinophils / FAB M4Eo
  98723https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia, minimal differentiation / Acute myeloblastic leukemia / FAB M0
  98733https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia without maturation / FAB M1
  98743https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with maturation / FAB M2, NOS
  98753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChronic myelogenous leukemia, BCR/ABL positive / Chronic granulocytic leukemia, BCR/ABL / Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive / Chronic granulocytic leukemia, t(9;22)(q34;q11) / Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive / Chronic myelogenous leukemia, t(9;22)(q34;11)
  98763https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAtypical chronic myeloid leukemia, BCR/ABL negative / Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative
  98773https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with mutated NPM1
  98783https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with biallelic mutation of CEBPA
  98793https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with mutated RUNX1
  98913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute monocytic leukemia / Monoblastic leukemia, NOS / Acute monoblastic leukemia / FAB M5 / Acute monoblastic and monocytic leukemia
  98953https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia with myelodysplasia-related changes / Acute myeloid leukemia with multilineage dysplasia / Acute myeloid leukemia with prior myelodysplastic syndrome / Acute myeloid leukemia without prior myelodysplastic syndrome
  98963https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia, t(8;21)(q22;q22) / Acute myeloid leukemia, AML1(CBF-alpha)/ETO / Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 / FAB M2, AML1(CBF-alpha)/ETO / FAB M2, t(8;21)(q22;q22)
  98973https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia, 11q23 abnormalities / Acute myeloid leukemia, MLL / Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL
  98983https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid leukemia associated with Down Syndrome
  99103https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute megakaryoblastic leukemia / Megakaryocytic leukemia / FAB M7
  99113https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
  99123https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute myleoid leukemia with BCR-ABL1
  99203https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTherapy related myeloid neoplasm / Therapy-related acute myeloid leukemia, NOS / Therapy-related acute myeloid leukemia, alkylating agent related / Therapy-related acute myeloid leukemia, epipodophyllotoxin-related
  99303https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid sarcoma / Chloroma / Granulocytic sarcoma
  99313https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAcute panmyelosis with myelofibrosis / Acute myelosclerosis, NOS / Acute panmyelosis, NOS / Acute myelofibrosis / Malignant myelosclerosis
  99403https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyHairy cell leukemia / Hairy cell leukemia variant / Leukemic reticuloendotheliosis
  99453https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChronic myelomonocytic leukemia, NOS / Chronic myelomonocytic leukemia, Type I / Chronic myelomonocytic leukemia, Type II / Chronic myelomonocytic leukemia in transformation
  99463https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyJuvenile myelomonocytic leukemia / Juvenile chronic myelomonocytic leukemia
  99483https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyAggressive NK-cell leukemia
  99503https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPolycythemia vera / Chronic erythremia / Polycythemia rubra vera / Proliferative polycythemia
  99603https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloproliferative neoplasm, NOS / Chronic myeloproliferative disease, NOS / Chronic myeloproliferative disorder / Myeloproliferative disease, NOS
  99613https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyPrimary myelofibrosis / Agnogenic myeloid metaplasia / Chronic idiopathic myelofibrosis / Megakaryocytic myelosclerosis / Myelofibrosis as a result of myeloproliferative disease / Myelofibrosis with myeloid metaplasia / Myelosclerosis with myeloid metaplasia
  99623https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyEssential thrombocythemia / Essential hemorrhagic thrombocythemia / Idiopathic hemorrhagic thrombocythemia / Idiopathic thrombocythemia
  99633https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChronic neutrophilic leukemia
  99643https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyChronic eosinophilic leukemia, NOS / Hypereosinophilic syndrome
  99653https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid and lymphoid neoplasms with PDGFRA rearrangement
  99663https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid neoplasms with PDGFRB rearrangement
  99673https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid and lymphoid neoplasms with FGFR1 abnormalities
  99683https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloid and lymphoid neoplasms with PCM1-JAK2
  99753https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyeloproliferative neoplasm, unclassifiable / Myelodysplastic/myeloproliferative neoplasm, unclassifiable
  99803https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory anemia / Refractory anemia without sideroblasts / Myelodysplastic syndrome with single lineage dysplasia
  99823https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory anemia with sideroblasts / RARS / Refractory anemia with ring sideroblasts associated with marked thrombocytosis / Refractory anemia with ringed sideroblasts
  99833https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory anemia with excess blasts / RAEB / RAEB I / RAEB II
  99843https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory anemia with excess blasts in transformation / RAEB-T
  99853https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory cytopenia with multilineage dysplasia / Myelodysplastic syndrome with multilineage dysplasia / Refractory cytopenia of childhood
  99863https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyelodysplastic syndrome with 5q deletion (5q-) syndrome / Myelodysplastic syndrome with isolated del (5q)
  99873https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyTherapy-related myelodysplastic syndrome, NOS / Therapy-related myelodysplastic syndrome, alkylating agent related / Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related
  99893https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyelodysplastic syndrome, NOS / Myelodysplastic syndrome, unclassifiable / Preleukemia / Preleukemic syndrome
  99913https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory neutropenia
  99923https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyRefractory thrombocytopenia
  99933https://hapi.fhir.tw/fhir/CodeSystem/ICD-O-3-MorphologyMyelodysplastic syndrome with ring sideroblasts and multilineage dysplasia

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code